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Abstract
Background: There is a clear relationship between depression and diabetes. However, the directionality of the relationship
remains unclear and very little research has considered a multi-ethnic population. The aim of this study was to determine
the prevalence of depression in a White-European (WE) and South-Asian (SA) population attending a community diabetes
screening programme, and to explore the association of depression with screen-detected Type 2 diabetes mellitus (T2DM)
and impaired glucose regulation (IGR).
Methodology/Principal Findings: Participants were recruited from general practices in Leicestershire (United Kingdom)
between August 2004 and December 2007. 4682 WE (40–75 years) and 1327 SA participants (25–75 years) underwent an
Oral Glucose Tolerance Test, detailed history, anthropometric measurements and completed the World Health Organisation-
Five (WHO-5) Wellbeing Index. Depression was defined by a WHO-5 wellbeing score #13. Unadjusted prevalence of
depression for people in the total sample with T2DM and IGR was 21.3% (21.6% in WE, 20.6% in SA, p=0.75) and 26.0%
(25.3% in WE, 28.9% in SA, p=0.65) respectively. For people with normal glucose tolerance, the prevalence was 25.1%
(24.9% in WE, 26.4% in SA, p=0.86). Age-adjusted prevalences were higher for females than males. Odds ratios adjusted for
age, gender, and ethnicity, showed no significant increase in prevalent depression for people with T2DM (OR=0.95, 95%CI
0.62 to 1.45) or IGR (OR=1.17, 95%CI 0.96 to1.42).
Conclusions: Prior to the knowledge of diagnosis, depression was not significantly more prevalent in people with screen
detected T2DM or IGR. Differences in prevalent depression between WE and SA people were also not identified. In this
multi-ethnic population, female gender was significantly associated with depression.
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Introduction
Psychological distress anddepressioncanoftenmanifestinpeople
with chronic illnesses [1]. Previous research has suggested the
presence of an association between depression and Type 2 diabetes
mellitus (T2DM)[2–13]. A recent meta-analysis found that the odds
of co-morbid depression were greater amongst people with diabetes
compared to those without [1]. Ethnic disparities were also found
for prevalent co-morbid depression in individuals with T2DM,
whereby significantly higher rates were identified in South-Asian
compared to White-European people, and adjustments for age and
gender did not alter these differences [14]. Additionally, other
research has argued that depression may be a consequence of living
with a diagnosis of diabetes [6], particularly considering the
psychological issues relating to disease acceptance and self-
management, and the health concerns that may arise from the
experience of complications [8]. A study by Knol et al [9] for
example,foundthat theincidenceofanti-depressantuse washighest
2 months prior to and 3 months following initiation of treatment for
T2DM, thereby suggesting the potential impact of diagnosis,
commencement of a medication schedule, and disease burden on
the psychological wellbeing of patients newly identified with the
condition. Interestingly, however, the Diabetes and Self-Manage-
ment for Ongoing and Newly Diagnosed Diabetes (DESMOND)
trial, found comparable rates of depression in people newly
diagnosed with T2DM and the general population [15].
It is apparent, therefore, that the underlying mechanism of the
relationship between depression and diabetes still remains unclear
[6]. What is evident, however, is that the resulting physical,
psychological, social and economic implications are dire [4].
People with depression and diabetes often experience poorer
quality of life, self-neglect in terms of diet, physical activity and
treatment adherence, and increased morbidity and mortality [1].
Consequently, it is important to improve the understanding of this
association to further guide development and implementation of
preventative strategies, and therefore improve this morbidity [6].
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between depression and previously unrecognised glucose intoler-
ance or screen-detected diabetes. In contrast to people with
diabetes and co-morbid depression, individuals with screen-
detected diabetes and depression would be unaware of their
glucose tolerance status prior to undergoing an Oral Glucose
Tolerance Test (OGTT). It is, therefore, important to explore the
relationship between screen-detected diabetes and depression
further, particularly given the potential, through longitudinal
studies, to investigate the directionality and time-line associated
with the experience of depression.
Recent cross-sectional studies with a screen-detected population
completed in Germany [6] and the US [8] did not find an
association between depressive symptoms and unrecognised glucose
intolerance, though the latter study found significantly lower
prevalence of depressive symptoms in males relative to females. A
recent study from the UK [16] found the odds of diabetes to be
significantly greater in people with diabetes, in addition to a
significant association of 2 hour plasma glucose following an
OGTT with depression scores on the Hospital Anxiety and
Depression Scale (HADS). The population under investigation in
this study was, however, comprised of a high proportion of people
from more affluent socio-economic backgrounds and people from
an older age group (mean age of 66 years). Further, the ethnicity of
study participants was not considered.
Although these studies seemed to indicate that the experience of
depression may occur long after a diagnosis of T2DM, the results
are inconclusive and require further investigation [6,8]. Very little
research has been completed in the UK for a screen-detected or ‘at
risk’ population, and specific consideration has not been made to
ethnicity related disparities. South-Asian people are recognised,
however, as having an increased susceptibility for the development
of T2DM [17,18] and also for depression [19]. Asghar et al [20]
found high overall rates of depression in native South-Asian people
with newly recognised diabetes, which were comparable to those
in the general population of Bangladesh. The study also found that
prevalent depression was again consistently higher amongst
females compared to males.
The present study is aiming to investigate the prevalence of
depression in South-Asian and White-European people attending
a diabetes screening programme. The study also proposes to
further examine the association of depression with screen-detected
diabetes and impaired glucose regulation (IGR).
Methods
Participant Recruitment
The study was carried out in accordance with the principles
summarised in the 1996 Helsinki Declaration, and all participants
provided written informed consent of their willingness to be
involved. After obtaining ethical approval from the Leicestershire
local research ethics committees and the Leicestershire, North-
amptonshire and Rutland Research Committee 1, participants
were recruited to this community screening study.
Participants were recruited from 46 general practices in
Leicestershire (UK) between August 2004 and December 2007.
Baseline measurements were taken during this time period. A
member of the research team met with participating practices to
review patient lists and provide assistance with the process of
identifying patients eligible to participate, as well as with extraction
of patient data. For maintenance of confidentiality, all initial
database searches and mailings were performed by practice staff.
White-European individuals aged between 40 and 75 were
recruited to participate in this study, while people of South-Asian
ethnicity were recruited from the age of 25 to 75 years. South-
Asian people were identified using the Nam Pehchan software,
developed by Bradford City Council from census data [21]. People
were only eligible to participate provided that they had not
previously received a diagnosis of T2DM. Though, many of the
participants had at least one risk factor for T2DM present at the
time of recruitment. People with a terminal illness were excluded.
All eligible patients (65,416 people) were posted details about
the study, together with a returnable request form for language-
specific information written in the major South-Asian languages
(Hindi, Gujarati, Bengali, Urdu and Punjabi). Patients expressing
an interest in the study were offered individual screening
appointments (32, 296 people). Screening took place at the two
main hospitals in Leicester (UK), in general practices or on a
purpose built mobile screening unit located in their local
community, by qualified research nurses. Those patients who
did not respond to the first mailing were sent a further mailing
within 6 months. Overall, 6749 people were screened which
demonstrates a low uptake of screening, with only around 20% of
those invited attending for screening. The present paper involves a
sub-set of this cohort.
Assessments
Glucose tolerance was assessed using a 75 g OGTT, whereby
individuals were asked to fast for eight hours prior to attending a
screening appointment and also to bring a list of prescribed
medications with them. Participants were classified by the World
Health Organisation (WHO) diagnostic criteria [22]. IGR was
defined as Impaired Fasting Glycaemia (IFG) (fasting glucose $6.1
and ,7.0 mmol/l) and/or Impaired Glucose Tolerance (IGT)
(2 hour glucose $7.8 and ,11.1 mmol/l). Cut-off points for
diabetes were fasting glucose $7.0 and/or 2 hour glucose
$11.1 mmol/l [22].
Depression was assessed with the World Health Organisation-
Five Wellbeing Index (WHO-5), which is designed to assess the
absence of positive mood, using five-items on a six-point frequency
scale [23]. WHO-5 attempts to establish a score for the extent to
which a person has experienced positive well-being in the two weeks
prior to assessment [24,25]. Although raw scores can vary between
0 and 25, lower scores demonstrate a poor overall feeling of well-
being [26]. A cut-point of less than or equal to 13 (#13) has been
proven to offer a 94% sensitivity and 65% specificity as a diagnostic
tool for depression [26] with acceptable findings for internal
consistency (a Cronbach’s alpha of 0.83 [27]). Compared with the
Brief Patient Health Questionnaire (B-PHQ) and General Health
Questionnaire (GHQ), the WHO-5 was found to be superior for use
as a screening tool for depression in primary care [26]. For this
study, the English language version of the WHO-5 was used for all
participants. Translated versions of the WHO-5 are not currently
available for the main South-Asian languages. However, the scale
has been used in a native Indian population [28].
Participants also completed a detailed history, including; family
history of T2DM, smoking status, and physical activity levels, by
self-report. A diagnosis of diabetes was assessed with computer
searches of general practice medical records, and data on other
medical conditions (including, pre-existing history of depression)
was self-reported by patients on examination. Physical activity was
measured with the short-format International Physical Activity
Questionnaire (IPAQ), which assesses moderate to vigorous
intensity activities carried out for greater than 10 minutes within
the previous 7 days, using four generic items [29]. Anthropometric
measurements, such as; height, weight, and waist circumference
were also obtained. Further biochemical measurements, including;
glycosylated haemoglobin (HbA1c) were also assessed. Demo-
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postcode was used to calculate the Index of Multiple Deprivation
(IMD), which is a deprivation score for small areas in England
based on a combination of a number of domains encompassing
economic, social and housing factors, and enables ranking of areas
according to their specific level of deprivation [30].
Statistical Methods
The present analysis included only those individuals involved in
the study who were of White-European or South-Asian ethnicity.
Additionally, as South-Asian participants were recruited from a
younger age than White-Europeans, the analysis focused only on
those individuals within the 40 to 75 year age group. Participants
with missing data were excluded prior to statistical analysis.
Throughout the present analysis, statistical significance was
assessed at the 5% level.
Unadjusted prevalence figures for depression (with 95%
confidence intervals) were calculated for T2DM, IGR and people
with normal glucose tolerance (NGT), separately for White-
European and South-Asian participants, and males and females.
Interactions between ethnicity and T2DM, IGR and NGT were
investigated, as were interactions of sex with T2DM, IGR and
NGT. Age-stratified prevalence figures were calculated following
categorisation of the continuous age variable into two strata (40–
59, 60 and over). The age-adjusted prevalence was calculated
based on a logistic regression model. Continuous age was used to
calculate the age-adjusted prevalence.
In addition, continuous relationships between wellbeing score
and fasting and two-hour plasma glucose levels were explored with
scatterplots. A logarithmic transformation to base e was attempted
for the highly skewed plasma glucose measurements.
To analyse the association of depression with screen-detected
T2DM and IGR, logistic regression was performed with
depression (yes/no) as the outcome, and T2DM and IGR as
predictor variables. Initially, an investigation into the potential
confounders of this relationship was undertaken using the t-test for
continuous variables and the chi-squared test for categorical data.
The Bonferroni adjustment was also applied to account for
multiple testing. Variables related to both T2DM or IGR and
depression were included in a logistic regression model. Age,
gender, and ethnicity were forced into the logistic regression model
regardless of statistical significance, on the basis that these
variables were important effect modifiers rather than confounding
factors. Odds ratios and 95% confidence intervals (95%CI) were
obtained. Statistical analyses were completed using STATA 9
(StataCorp LP, College Station, TX, USA).
Results
Descriptive Analysis
Descriptive statistics are summarised in table 1. Overall, 6009
participants were involved in the analysis of this study; 4682 (78%)
people of White-European (WE) ethnicity, and 1327 (22%) South-
Asians (SA). Table 1 shows that the unadjusted prevalence for
screen-detected T2DM was 3.4% (95%CI 2.9–3.8) and 14.4%
(95%CI 13.4–15.1) for IGR.
Table 2 illustrates that South-Asian participants were significantly
younger than the White-Europeans. Fasting and 2-hour plasma
glucose levels were significantly higher amongst South-Asian
participants, as was HbA1c. South-Asian people had significantly
l o w e rb o d ym a s si n d e x( B M I )t h a nW h i t e - E u r o p e a n s ,a sw e l la sa
significantly lower waist circumference. South-Asian people also had
a significantly higher IMD score, which indicated a greater level of
deprivation than White-European participants. South-Asian people
were significantly less often a current smoker or an ex-smoker, were
less often physically active and more often had a family history of
T2DM, compared to White-European participants.
81% of participants had complete data for the WHO-5.
Though significant differences in wellbeing scores could not be
established between White-European and South-Asian partici-
pants, wellbeing scores were found to be significantly lower among
female participants than males (mean=16 (SD=4.92) versus 17
(SD=4.53) in females and males respectively, p,0.001).
Further descriptive analyses were not able to identify a
relationship of wellbeing score with logarithmic transformed
fasting and two-hour plasma glucose levels for White-European
or South-Asian participants. Also, 1.7% of participants were found
to have a pre-existing history of depression with varying levels of
severity (including, mixed depression and anxiety, bipolar disorder
and co-morbid depression). Of this proportion, 3.9% had screen-
detected T2DM and 16.3% had IGR.
Table 1. Descriptive statistics for the study population, mean
(standard deviation) unless otherwise stated.
Gender (N (%))
Male 2849 (47)
Female 3160 (53)
Ethnicity (N (%))
White-European 4682 (78)
South-Asian 1327 (22)
Diagnosis (N (%))
Type 2 diabetes 198 (3.4)
Impaired glucose regulation 855 (14.4)
Normal 4956 (82.5)
Depressed (N (%)) 1231 (25.2)
Age (years) N=6003 58(9.7)
Fasting glucose at screening (mmol/l) N=6001 5.2 (0.9)
2-hour glucose at screening (mmol/l) N=5973 6.0 (2.5)
Hba1C (%) N=5941 5.7 (0.6)
Wellbeing Score N=4895 16 (5)
Body Mass Index (BMI) (kg/m
2) N=5980 28.1 (5)
Waist (cm) N=5977 94.2 (13.2)
Index of Multiple Deprivation (IMD) Score N=5337 18.2 (12.3)
Smoking status (N (%))
Non-smoker 3425 (57)
Current smoker 847 (14)
Ex-smoker 1713 (28.5)
Total 5985
Physical activity (N (%))
Low 1434 (25.9)
Moderate 939 (17)
Vigorous 3163 (57.1)
Total 5536
Family history of Type 2 diabetes (N (%))
First degree relative 1338 (22.3)
Non-first degree relative 122 (2)
None 4547 (75.7)
Total 6007
doi:10.1371/journal.pone.0007755.t001
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Unadjusted prevalence figures are presented in table 3.
Prevalence figures were very similar for T2DM, IGR and NGT,
though were slightly elevated for the latter two groups compared
to T2DM. Statistical significance in the differences between
prevalent depression between males and females, or White-
European and South-Asian people could not be established.
However, prevalence figures were elevated for females compared
to males with T2DM, IGR or NGT.
Age-adjusted prevalence figures (table 4) were consistently
increased for females compared to males, particularly amongst
women of South-Asian ethnicity. Though, prevalent depression
did not differ significantly by sex and ethnicity (p=0.38). Across all
groups, prevalence figures were greatest for those with IGR, and
were lower among those with screen-detected T2DM; however,
these differences were only marginal. It was clear, however, that
depression was more prevalent in people with NGT, in
comparison to those with T2DM. Overall, age-adjusted preva-
lences were elevated across T2DM, IGR and NGT, and there was
only marginal variation in figures across all groups.
Association of Depression with Diabetes
A statistically significant association of depression with screen-
detected T2DM or IGR was not identified in any of the
unadjusted or adjusted models (table 5). Addition of further
variables in models 2 and 3 did not affect the relationship between
depression and T2DM or IGR. Statistically significant associations
Table 2. Differences in characteristics between White-European and South-Asian participants, mean (standard deviation) unless
otherwise stated.
White-European (N=4688) South-Asian (N=1340) P-Value
Age (years) N=4678 59.2 (9.6) N=1325 53.6 (8.8) ,0.001
Wellbeing Score N=4131 16.15 (4.71) N=764 16.16 (5.07) 0.96
Fasting glucose at screening (mmol/l) N=4677 5.2 (0.9) N=1324 5.3 (0.9) 0.001
2-hour glucose at screening (mmol/l) N=4654 5.9 (2.4) N=1319 6.5 (2.7) ,0.001
Hba1C (%) N=4641 5.7 (0.6) N=1300 5.9 (0.6) ,0.001
Body Mass Index (BMI) (kg/m
2) N=4655 28.3 (5) N=1325 27.5 (4.9) ,0.001
Waist (cm) N=4655 94.7 (13.5) N=1322 92.6 (11.9) ,0.001
Index of Multiple Deprivation (IMD) Score N=4225 16.9 (11.7) N=1112 23.5 (13.1) ,0.001
Depressed status (Yes (%)/Total) 1028 (24.9)/4131 203 (26.5)/764 0.32
Smoking status (N (%))
Non-smoker 2312 (49.6) 1113 (84.3) ,0.001
Current smoker 743 (15.9) 104 (7.9) ,0.001
Ex-smoker 1610 (34.5) 103 (7.8) ,0.001
Total 4665 1320
Physical activity (N (%))
Low 925 (20.9) 509 (46)
Moderate 765 (17.3) 174 (15.7)
Vigorous 2740 (61.9) 423 (38.2)
Total 4430 1106 ,0.001
Family history of Type 2 diabetes (N (%))
First degree relative 3655 (78) 892 (67.3)
Non-first degree relative 102 (2.2) 20 (1.5)
None 924 (19.7) 414 (31.2)
Total 4687 1326 ,0.001
doi:10.1371/journal.pone.0007755.t002
Table 3. Unadjusted prevalence of depression for White-
European and South-Asians, and males and females.
T2DM IGR NGT
% Prevalence (95% CI)
r/n
White-Europeans 21.6 (14.0–30.8) 25.3 (21.7–29.3) 24.9 (23.5–26.4)
22/102 134/529 872/3500
South-Asians 20.6 (8.7–37.9) 28.9 (20.8–38.2) 26.4 (23.0–30.1)
7/34 33/114 163/616
P-value 0.75 0.65 0.86
Males 18.4 (10.8–28.1) 19.9 (15.7–24.8) 21.1 (19.3–23.0)
16/87 63/316 412/1952
Females 26.5 (14.9–40.1) 31.8 (26.8–37.2) 28.8 (26.9–30.7)
13/49 104/327 623/2164
P-value 0.95 0.29 0.27
Overall 21.3 (14.8–29.2) 26.0 (22.6–29.5) 25.1 (23.8–26.5)
29/136 167/643 1035/4116
r denotes observed number with depression in each group.
n denotes total number of people in that particular group.
doi:10.1371/journal.pone.0007755.t003
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(models 2 and 3, table 5). Females had a statistically significant
odds ratio of 1.55 compared to males when controlling for age and
ethnicity (model 2, table 5), which increased greatly with further
adjustment for BMI, current smoking status, physical activity,
waist circumference and IMD score (model 3, table 5). Therefore,
with adjustment, females had a significant 84% increase in the
odds of depression, compared to males. A statistically significant
association was apparent for depression with age in models 2 and 3
(table 5). Addition of confounding factors in model 3 did not affect
the association of depression with ethnicity or age.
Of the confounders included in the model, significant
independent associations with depression emerged for waist
circumference, IMD and BMI (model 3, table 5). Though the
associations for these variables were statistically significant, it is
important to note that the odds ratios and 95% confidence
intervals only suggested a marginal effect, and these variables
were included only as confounding factors. Similarly, following
adjustment, significant odds ratios were found for current
smokers, people undertaking moderate physical activity and for
people undertaking vigorous levels of physical activity (model 3,
table 5).
Discussion
The present study aimed to explore the prevalence of depression
in South-Asian and White-European people attending a diabetes
screening programme, and also to further examine the association
of depression with screen-detected diabetes and IGR. With respect
Table 5. Logistic regression with depression as the outcome,
inclusive of unadjusted models and models adjusted for
confounding factors.
Odds Ratio (95% CI) P-value
Model 1
Screen-detected T2DM vs. Normal* 0.81 (0.53–1.22) 0.31
IGR vs. Normal* 1.04 (0.86–1.26) 0.65
Model 2
Screen-detected T2DM vs. Normal* 0.95 (0.62–1.45) 0.82
IGR vs. Normal* 1.17 (0.96–1.42) 0.12
South-Asian vs. White-European* 0.92 (0.77–1.11) 0.40
Female vs. Male* 1.55 (1.36–1.77) ,0.001
Age 0.97 (0.97–0.98) ,0.001
Model 3
Screen-detected T2DM vs. Normal* 0.74 (0.44–1.23) 0.24
IGR vs. Normal* 1.10 (0.89–1.36) 0.38
South-Asian vs. White-European* 0.92 (0.75–1.14) 0.47
Female vs. Male* 1.83 (1.52–2.20) ,0.001
Age 0.97 (0.96–0.98) ,0.001
Moderate exercise vs. No moderate exercise* 0.71 (0.57–0.88) ,0.01
Vigorous exercise vs. No vigorous exercise* 0.54 (0.45–0.65) ,0.001
Current smoker vs. Non-current smoker* 1.72 (1.42–2.08) ,0.001
Waist circumference 1.02 (1.01–1.03) ,0.01
BMI 0.98 (0.95–1.01) 0.17
IMD Score 1.01 (1.00–1.02) ,0.01
*Denotes reference category.
doi:10.1371/journal.pone.0007755.t005
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the knowledge of diagnosis, depression was not significantly more
prevalent in people with screen-detected T2DM or IGR. Prevalent
depression did not differ significantly across White-European and
South-Asian participants, though the study did find that
depression was significantly higher in prevalence among females
than males.
The findings from the present study are largely consistent with
those demonstrated in previous research by Icks et al [6] and Rhee
et al [8], whereby an association of depression with screen detected
T2DM or IGR could not be identified. Although previous studies
have found that co-morbid depression is significantly more
prevalent in people with diabetes, the results from this study and
others using a screen-detected population are important to add to
our understanding of the mechanism of the relationship between
depression and diabetes. Findings that demonstrate statistical non-
significance for this association in a screen-detected population
may indicate the likely progression to developing depression
following a diagnosis of diabetes. This may possibly be the case
when comparing the present results to those found by Ali et al [14]
whose work identified rates of depression in White-European and
South-Asian people with established T2DM to be at around 22%
and 32%, respectively. It could be that people eligible to
participate in diabetes screening studies, such as in the present
study, may have an increased susceptibility for depression prior to
the knowledge of glucose tolerance status. It would be interesting
to follow these people up in a prospective study to add further
knowledge to the directionality of the relationship between
depression and diabetes. Prevalence figures in the Ali et al study
[14] were obtained with the HADS. Comparison of the present
results to normative data for the WHO-5 in a UK population has
not been possible as this data has not yet been published.
Though statistically significant, differences in fasting and two
hour glucose levels between White-European and South-Asian
people in the present study cannot be considered as clinically
relevant, in accordance with the WHO criteria [22]. Similarly,
HbA1c levels are slightly below the 6 or greater ($6) and less than
6.5 (,6.5) criteria for clinical significance in terms of diagnosing
diabetes [31]. According to National Institute for Health and
Clinical Excellence (NICE) clinical guidance [32], however,
average BMI in the present study can be interpreted as indicative
of overweight, particularly with the lower values of BMI that are
considered clinically relevant for people of South-Asian ethnicity.
Similar can be interpreted from the large waist circumference
measurements demonstrated in the present study, in accordance
with International Diabetes Federation (IDF) guidelines for clinical
significance [33].
The present findings did offer support for previous findings from
other studies demonstrating a greater prevalence of depression in
females compared to males [1,6,20]. The extent to which the
findings regarding ethnicity are consistent with other literature,
however, is challenging to discuss because of the paucity of studies
focusing on the relationship between depression and diabetes in a
South-Asian population. This is the first study to investigate these
differences between South-Asians and White-Europeans. For the
present sample, very few differences were found in prevalent
depression across White-European and South-Asian people. A
potential explanation for this could be related to the tool used to
assess depression in the present study. As previously mentioned,
the WHO-5 was implemented to assess well-being of study
participants, whereby those with a well-being score of 13 or lower
were considered to have poor well-being, and were therefore
classified as probable cases of depression. Previous research has
documented the adequacy of the #13 cut-point for detecting
depression (for example, Henkel et al [25]). Although previous
literature investigated the #13 cut-point on a number of patient
sub-groups; for example, males and females, and people aged
above or below 56 [25], research has not been completed into
evaluating the adequacy of the cut-point for detecting depression
in a predominantly South-Asian population. Therefore, though
the lack of differences found in prevalent depression between
South-Asian compared to White-European participants in the
present study may well be a true reflection of the sample, it is
important to recognise that the results may also be implying that
the well-documented #13 cut-point on the WHO-5 may not be
appropriate enough to detect depression for South-Asian people.
Similarly, it is also important to note that self-reported
depression was not confirmed with a diagnosis in accordance
with the Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV) from administration of a clinical interview with a
psychiatrist or psychologist. Depressed cases in the present study
were identified purely on the basis of diagnosis of well-being from
the WHO-5. Therefore, the figures presented in this paper may be
an over or underestimate of the prevalence of depression, and
should really be supplemented with a gold-standard approach for
the purposes of future research. There is ongoing debate around
measures for wellbeing, whereby some researchers argue for the
increased sensitivity in assessing the absence of positive mood in
people, in comparison to common measures of depression, which
tend to focus on the presence of negative mood.
The present analysis did not have access to any data
representing the use of anti-depressants in the sample. WHO-5
assesses wellbeing in the two weeks prior to self-report. For
participants who have previously taken anti-depressant medication
or are currently receiving treatment for depression, their mood
state at the time of measurement may be considerably more
positive than would have been if they were not receiving
medication. Therefore, the prevalence figures for depression in
the present study may not be an adequate representation of the
sample, and may be an underestimation. Furthermore, as with
most studies investigating the relationship of depression with
T2DM, the present study was based on cross-sectional data, so it
would not be possible to determine any patterns of causation or
temporal relationships.
Although the study was limited in some aspects, it also has a
number of strengths. Our study was particularly strong in the large
sample size that was available for analysis. This provided a greater
statistical power to detect an association of depression with screen
detected T2DM and IGR, should any have really existed. We also
explored potential confounders in the analysis (for example, age,
sex and BMI). On the basis that Ali et al [1] recognised that
previous research neglected to adequately account for confound-
ers, the present study was positive in that the models developed
were appropriately adjusted for the influence of all potential
confounders. A major strength of the study was also in the use of
an OGTT to assess glucose tolerance. In addition, our study was
the first to investigate the association of depression with
unrecognised glucose intolerance in a multi-ethnic population
with a high proportion of South-Asian participants. This is
obviously an area that has been neglected by previous research but
ethnicity related disparities are important to investigate further,
given the increasing prevalence of T2DM amongst this popula-
tion.
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